Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = systemic lupus erythaematosus

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
14 pages, 1080 KiB  
Review
Circulating Free DNA and Its Emerging Role in Autoimmune Diseases
by Patricia Mondelo-Macía, Patricia Castro-Santos, Adrián Castillo-García, Laura Muinelo-Romay and Roberto Diaz-Peña
J. Pers. Med. 2021, 11(2), 151; https://doi.org/10.3390/jpm11020151 - 20 Feb 2021
Cited by 46 | Viewed by 6072
Abstract
Liquid biopsies can be used to analyse tissue-derived information, including cell-free DNA (cfDNA), circulating rare cells, and circulating extracellular vesicles in the blood or other bodily fluids, representing a new way to guide therapeutic decisions in cancer. Among the new challenges of liquid [...] Read more.
Liquid biopsies can be used to analyse tissue-derived information, including cell-free DNA (cfDNA), circulating rare cells, and circulating extracellular vesicles in the blood or other bodily fluids, representing a new way to guide therapeutic decisions in cancer. Among the new challenges of liquid biopsy, we found clinical application in nontumour pathologies, including autoimmune diseases. Since the discovery of the presence of high levels of cfDNA in patients with systemic lupus erythaematosus (SLE) in the 1960s, cfDNA research in autoimmune diseases has mainly focused on the overall quantification of cfDNA and its association with disease activity. However, with technological advancements and the increasing understanding of the role of DNA sensing receptors in inflammation and autoimmunity, interest in cfDNA and autoimmune diseases has not expanded until recently. In this review, we provide an overview of the basic biology of cfDNA in the context of autoimmune diseases as a biomarker of disease activity, progression, and prediction of the treatment response. We discuss and integrate available information about these important aspects. Full article
(This article belongs to the Special Issue Personalized Medicine in Autoimmune Diseases)
Show Figures

Figure 1

Back to TopTop